Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
- Published In:
- The Journal of clinical endocrinology and metabolism, 110(1), 1-15 (2024)
- Authors:
- Jalleh, Ryan J, Plummer, Mark P, Marathe, Chinmay S(2), Umapathysivam, Mahesh M, Quast, Daniel R, Rayner, Christopher K, Jones, Karen L, Wu, Tongzhi, Horowitz, Michael, Nauck, Michael A
- Database ID:
- RPEP-08450
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08450APA
Jalleh, Ryan J; Plummer, Mark P; Marathe, Chinmay S; Umapathysivam, Mahesh M; Quast, Daniel R; Rayner, Christopher K; Jones, Karen L; Wu, Tongzhi; Horowitz, Michael; Nauck, Michael A. (2024). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.. The Journal of clinical endocrinology and metabolism, 110(1), 1-15. https://doi.org/10.1210/clinem/dgae719
MLA
Jalleh, Ryan J, et al. "Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.." The Journal of clinical endocrinology and metabolism, 2024. https://doi.org/10.1210/clinem/dgae719
RethinkPeptides
RethinkPeptides Research Database. "Clinical Consequences of Delayed Gastric Emptying With GLP-1..." RPEP-08450. Retrieved from https://rethinkpeptides.com/research/jalleh-2024-clinical-consequences-of-delayed
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.